Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Dexamethasone Palmitate for Prophylaxis of Postoperative Nausea and Vomiting After Minimally Invasive Endoscopic Surgery

NCT06981754 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT06981754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06981754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Dexamethasone Palmitate for Prophylaxis of Postoperative Nausea and Vomiting After Minimally Invasive Endoscopic Surgery
Lead sponsor
Beijing Tiantan Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 17, 2025
Completion date
May 2, 2026
Enrollment
588 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexamethasone palmitate, minimally invasive endoscopic procedures, postoperative nausea and vomiting